BridgeMD
New treatment option for Helicobacter Pylori Eradication Rate
Official title Optimization of Keverprazan-amoxicillin Dual Therapy for Eradicating Helicobacter Pylori Infection
ClinicalTrials.gov ID: NCT06734260
What this study is testing
What is Keverprazan Hydrochloride tablets + high dose amoxicillin?
Keverprazan Hydrochloride tablets + high dose amoxicillin is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for helicobacter pylori eradication rate.
Also referred to as H-KA-14d.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Eradication of HP can significantly improve and reduce HP-related diseases. A 10-14 day quadruple regimen containing bismuth as first-line treatment, achieving an eradication rate of more than 85%.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75. Healthy volunteers may be eligible.
You may be able to join if
- Aged 18 to 75 years;
- Adult people who voluntarily signed written informed consent approved by the ethics committee to consent to participate in this study before the...
- people who can understand and comply with the protocol requirements and agree to attend all study visits;
- During the screening phase, patients who were Hp positive and required Hp eradication therapy as judged by the investigator, and patients who had...
- Participants agreed to use appropriate medical methods of contraception (except medically sterilized status) during the study.
You likely can't join if
- 1\. Participated in other clinical studies within 4 weeks before screening; 2. Pregnant or lactating women; 3. Known allergy to keverprazan...
The study team makes the final eligibility decision.
Where it's taking place
- Guangzhou, Guangdong, China
- Puning, Guangdong, China
- Shenzhen, Guangdong, China
- Xiangyang, Hubei, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Guangzhou, Guangdong, China; Puning, Guangdong, China; Shenzhen, Guangdong, China; Xiangyang, Hubei, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.